Share this
Bristol Myers Squibb to Acquire Turning Point Therapeutics for $4.1 Billion
Kronos Bio – $288 million IPO
Turning Point Therapeutics - $192 Million IPO
Allogene Therapeutics – $372.6 Million IPO
Cidara Completes Initial Public Offering
Sientra Completes $75 Million Initial Public Offering
Ambit Biosciences to be Acquired by Daiichi Sankyo for $410 Million
Kite Pharma $146 Million Initial Public Offering
Trius Therapeutics Acquisition by Cubist Pharmaceuticals
Measurabl Series A and Series B Financings